Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.

Ali A, Bailey C, Abdelhafiz AH.

Aging Dis. 2012 Aug;3(4):339-51. Epub 2012 Jun 21.

2.

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.

Xiang W, Zhang J, Liu M, Liu F, Feng X, Wang Y.

Clin Interv Aging. 2015 Mar 2;10:515-9. doi: 10.2147/CIA.S67974. eCollection 2015.

3.

Anticoagulation and atrial fibrillation.

Atwood JE, Albers GW.

Herz. 1993 Feb;18(1):27-38. Review.

PMID:
8454250
4.
5.

Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.

Chan EW, Lau WC, Siu CW, Lip GY, Leung WK, Anand S, Man KK, Wong IC.

Heart Rhythm. 2016 Aug;13(8):1581-8. doi: 10.1016/j.hrthm.2016.03.049. Epub 2016 Mar 28.

PMID:
27033342
6.

Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Kalabalik J, Rattinger GB, Sullivan J, Slugocki M, Carbone A, Rivkin A.

Drugs. 2015 Jun;75(9):979-98. doi: 10.1007/s40265-015-0405-y. Review.

PMID:
25998374
7.
8.

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.

Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.

PMID:
24486284
9.

Evaluation and management of atrial fibrillation.

Ali S, Hong M, Antezano ES, Mangat I.

Cardiovasc Hematol Disord Drug Targets. 2006 Dec;6(4):233-44. Review.

PMID:
17378769
10.

Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.

Grosset-Janin D, Barth E, Bertrand B, Detante O.

Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Review.

PMID:
25912470
11.

Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L.

Int J Cardiol. 2013 Sep 10;167(6):2682-7. doi: 10.1016/j.ijcard.2012.06.118. Epub 2012 Jul 15.

PMID:
22795403
12.

Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.

Brunetti L, Chen C, White J.

Consult Pharm. 2014 Mar;29(3):169-78. doi: 10.4140/TCP.n.2014.169. Review.

PMID:
24589766
13.

Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians.

Foody JM.

Clin Interv Aging. 2017 Jan 23;12:175-187. doi: 10.2147/CIA.S111216. eCollection 2017. Review.

14.

Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.

Seeger J, Bothner C, Dahme T, Gonska B, Scharnbeck D, Markovic S, Rottbauer W, Wöhrle J.

Clin Res Cardiol. 2016 Mar;105(3):225-9. doi: 10.1007/s00392-015-0910-8. Epub 2015 Aug 30.

PMID:
26318322
16.
17.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
18.

Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non-valvular atrial fibrillation patients: a multicenter propensity-matched analysis.

Kim TH, Kim JY, Mun HS, Lee HY, Roh YH, Uhm JS, Pak HN, Lee MH, Joung B.

J Thromb Haemost. 2015 Feb;13(2):182-90. doi: 10.1111/jth.12810. Epub 2015 Jan 7.

19.

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.

van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ; APACHE-AF Investigators..

Trials. 2015 Sep 4;16:393. doi: 10.1186/s13063-015-0898-4.

20.

Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded.

Man-Son-Hing M, Laupacis A.

Arch Intern Med. 2003 Jul 14;163(13):1580-6.

PMID:
12860581

Supplemental Content

Support Center